carbamates has been researched along with Niemann-Pick Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Civallero, G | 1 |
| De Mari, J | 1 |
| Bittar, C | 1 |
| Burin, M | 1 |
| Giugliani, R | 1 |
| Rosenbaum, AI | 1 |
| Cosner, CC | 1 |
| Mariani, CJ | 1 |
| Maxfield, FR | 1 |
| Wiest, O | 1 |
| Helquist, P | 1 |
2 other studies available for carbamates and Niemann-Pick Disease
| Article | Year |
|---|---|
Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
Topics: Carbamates; Cells, Cultured; Cholesterol Ester Storage Disease; Dried Blood Spot Testing; Fibroblast | 2014 |
Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics.
Topics: Carbamates; Cell Line; Enzyme Reactivators; Humans; Kinetics; Lipase; Lysosomes; Morpholines; Nieman | 2010 |